McFarland L V, Elmer G W, Stamm W E, Mulligan M E
Department of Epidemiology, University of Washington, Seattle 98195.
Infect Immun. 1991 Jul;59(7):2456-62. doi: 10.1128/iai.59.7.2456-2462.1991.
To determine whether strain-specific differences in immunoblot type, enterotoxin production, or cytotoxin production correlated with clinical presentation of Clostridium difficile infection, we evaluated isolates obtained from 428 prospectively studied hospitalized patients. Of 99 isolates available for immunoblot typing, 61 were recovered from asymptomatic carriers and 38 were from patients with C. difficile-associated diarrhea. Of 17 immunoblot types, the seven types comprising the majority of isolates (82 of 99; 83%) were variably associated with disease. Neither the presence of cytotoxin in the stool nor the production of cytotoxin or enterotoxin by isolates in vitro was significantly different for symptomatic versus asymptomatic patients. Selected host factors were more predictive of symptomatic disease than was the specific infecting C. difficile strain. These results suggest that variations in the clinical severity of C. difficile infection in different patients are not solely strain-specific phenomena related to immunoblot type or to the production of cytotoxin or enterotoxin.
为了确定艰难梭菌感染的免疫印迹类型、肠毒素产生或细胞毒素产生方面的菌株特异性差异是否与临床表现相关,我们评估了从428例前瞻性研究的住院患者中分离出的菌株。在99株可进行免疫印迹分型的菌株中,61株来自无症状携带者,38株来自艰难梭菌相关性腹泻患者。在17种免疫印迹类型中,构成大多数菌株的7种类型(99株中的82株;83%)与疾病存在不同程度的关联。有症状患者与无症状患者相比,粪便中细胞毒素的存在以及菌株在体外产生细胞毒素或肠毒素的情况均无显著差异。与特定感染的艰难梭菌菌株相比,选定的宿主因素对有症状疾病的预测性更强。这些结果表明,不同患者中艰难梭菌感染临床严重程度的差异并非仅仅是与免疫印迹类型或细胞毒素或肠毒素产生相关的菌株特异性现象。